Dongsung Pharm (002210) — Capital Reinvestment Ratio
Latest as of December 2024:
0.54x
Dongsung Pharm (002210) has a Capital Reinvestment Ratio of 0.54x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩3.01 Billion) in capital expenditures (₩1.62 Billion). See cash generation quality of Dongsung Pharm to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.54x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.01 Billion
KRW
Capital Expenditures
₩1.62 Billion
KRW
Data as of
Dec 2024
Most recent filing
Dongsung Pharm Capital Reinvestment Ratio (2010–2020)
This chart tracks Dongsung Pharm's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Dongsung Pharm (2010–2020)
Year-by-year Capital Reinvestment Ratio for Dongsung Pharm from 2010 to 2020. For live market cap and broader valuation context, see Dongsung Pharm (002210) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.38x | ₩5.01 Billion | ₩6.92 Billion | ▼ -9.5% |
| 2018 | 1.53x | ₩1.39 Billion | ₩2.13 Billion | ▼ -8.6% |
| 2017 | 1.67x | ₩1.80 Billion | ₩3.00 Billion | ▲ +626.3% |
| 2010 | 0.23x | ₩3.68 Billion | ₩847.33 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow